Intra-cellular therapies reports third quarter 2020 financial results and provides corporate update

P ositive topline results reported from study ‘402, a phase 3 study evaluating lumateperone as an adjunctive treatment to lithium or valproate in patients with bipolar depression.

ITCI Ratings Summary

ITCI Quant Ranking